Recombinant antibody fragments as autoantibody antagonists

Author：

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.13, Iss.1, 2003-01, pp. : 129-133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant Antibody Fragments for Neurodegenerative Diseases

Current Neuropharmacology, Vol. 15, Iss. 5, 2017-06 ,pp. : 779-788

Bentham Science Publishers

Access to resources Recommend Favorite

Production in yeasts of stable antibody fragments

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 2, 1997-02 ,pp. : 179-183

Informa Healthcare

Access to resources Recommend Favorite

Digoxin-Specific Antibody Fragments: How Much and When?

By Bateman D. Nicholas

Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol. 23, Iss. 3, 2004-01 ,pp. : 135-143

Adis International

Access to resources Recommend Favorite

Fab Antibody Fragments: Some Applications in Clinical Toxicology

By Robert J. Flanagan Alison L. Jones

Drug Safety, Vol. 27, Iss. 14, 2004-01 ,pp. : 1115-1133

Adis International

Access to resources Recommend Favorite

Risk of bacterial infections with antibody-based TNF antagonists

Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite